Security key
29286M113
enGene Therapeutics Inc. - *W EXP 10/31/202 (ENGNW)
CUSIP: 29286M113
Q3 2024 13F Holders as of 30 Sep 2024
- Security type / class
- Equity / *W EXP 10/31/202
- Total 13F shares
- 5,235,834
- Total 13F value
- $9,204,349
- Share change
- -37,149
- SEC-reported price per share
- $1.95
- Number of holders
- 14
- Value change
- -$41,253
- Number of sells
- 2
Report period
Q3 2024
Institutions
14
Top holders
10
ENGNW full security history
Ownership snapshot
Full 13F holder table
enGene Therapeutics Inc. SEC filings
enGene Therapeutics Inc. company facts
Broader feeds
Ownership snapshot
Top reported holders of ENGNW - enGene Therapeutics Inc. - *W EXP 10/31/202 (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
Fonds de solidarite des t...
Disclosed value leader
FCPM III SERVICES B.V.
Comparable rows
1/15
Latest evidence
30 Jun 2024
3/4/5
13D/G
13F
Lead comparable stake: 4.5%
14 rows are not safely comparable across share classes.
13D/G row: Fonds de solidarite des travailleurs et des travailleuses du Quebec
Showing 1-6 of 15 holder rows.
Quick read
Fonds de solidarite des travailleurs et des travailleuses du Quebec leads the comparable SEC ownership view at 4.5%.
1 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens Fonds de solidarite des travailleurs et des travailleuses du Quebec's linked filing trail.
Comparable ownership
Top 1
Fonds de solidarite des travaille...
4.5%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| Fonds de solidarite des travailleurs et des travailleuses du Quebec |
3/4/5
13D/G
10%+ Owner
|
4.5%
Reported 13D/G
· 30 Sep 2024
|
$45,542,295
3,036,153 shares
|
— | 18 Apr 2024 |
| Lumira Capital Investment Management Inc. |
3/4/5
10%+ Owner
|
—
denominator unverified
|
$38,492,990
3,849,299 shares
|
— | 20 Feb 2024 |
| Forbion Growth Sponsor FEAC I B.V. |
3/4/5
10%+ Owner
|
—
mixed-class rows
|
—
5,502,338 shares
mixed-class rows
|
— | 31 Oct 2023 |
| Forbion Capital Fund III Cooperatief U.A. |
3/4/5
10%+ Owner
|
—
denominator unverified
|
—
2,894,735 shares
|
— | 31 Oct 2023 |
| BVF PARTNERS L P/IL |
3/4/5
10%+ Owner
|
—
denominator unverified
|
—
104,257 shares
|
— | 31 Oct 2023 |
| FCPM III SERVICES B.V. |
13F
Company
|
—
mixed-class rows
|
$85,258,075
11,556,099 shares
mixed-class rows
|
— | 30 Jun 2024 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q3 2024
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
14
Shares
5,235,834
Rows available
14
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q3 2024 vs Q2 2024 Across Filers
Q2 2024 holders
14
Q3 2024 holders
14
Holder diff
0
| Investor | Q2 2024 Shares | Q3 2024 Shares | Share Diff | Share Chg % | Q2 2024 value | Q3 2024 value | Value change | Value Chg % |
|---|